The Health Effects of 72 Hours of Simulated Wind Turbine Infrasound: A Double-Blind Randomized Crossover Study in Noise-Sensitive, Healthy Adults.


Journal

Environmental health perspectives
ISSN: 1552-9924
Titre abrégé: Environ Health Perspect
Pays: United States
ID NLM: 0330411

Informations de publication

Date de publication:
03 2023
Historique:
entrez: 22 3 2023
pubmed: 23 3 2023
medline: 25 3 2023
Statut: ppublish

Résumé

Large electricity-generating wind turbines emit both audible sound and inaudible infrasound at very low frequencies that are outside of the normal human range of hearing. Sufferers of wind turbine syndrome (WTS) have attributed their ill-health and particularly their sleep disturbance to the signature pattern of infrasound. Critics have argued that these symptoms are psychological in origin and are attributable to nocebo effects. We aimed to test the effects of 72 h of infrasound (1.6-20 Hz at a sound level of We conducted a randomized double-blind triple-arm crossover laboratory-based study of 72 h exposure with a We randomized 37 noise-sensitive but otherwise healthy adults (18-72 years of age; 51% female) into the study before a COVID19-related public health order forced the study to close. WASO was not affected by infrasound compared with sham infrasound ( Our findings did not support the idea that infrasound causes WTS. High level, but inaudible, infrasound did not appear to perturb any physiological or psychological measure tested in these study participants. https://doi.org/10.1289/EHP10757.

Sections du résumé

BACKGROUND
Large electricity-generating wind turbines emit both audible sound and inaudible infrasound at very low frequencies that are outside of the normal human range of hearing. Sufferers of wind turbine syndrome (WTS) have attributed their ill-health and particularly their sleep disturbance to the signature pattern of infrasound. Critics have argued that these symptoms are psychological in origin and are attributable to nocebo effects.
OBJECTIVES
We aimed to test the effects of 72 h of infrasound (1.6-20 Hz at a sound level of
METHODS
We conducted a randomized double-blind triple-arm crossover laboratory-based study of 72 h exposure with a
RESULTS
We randomized 37 noise-sensitive but otherwise healthy adults (18-72 years of age; 51% female) into the study before a COVID19-related public health order forced the study to close. WASO was not affected by infrasound compared with sham infrasound (
DISCUSSION
Our findings did not support the idea that infrasound causes WTS. High level, but inaudible, infrasound did not appear to perturb any physiological or psychological measure tested in these study participants. https://doi.org/10.1289/EHP10757.

Identifiants

pubmed: 36946580
doi: 10.1289/EHP10757
pmc: PMC10032045
doi:

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

37012

Références

Hum Neurobiol. 1982;1(3):195-204
pubmed: 7185792
Health Psychol. 2014 Apr;33(4):360-4
pubmed: 23477573
Sleep. 2022 Mar 14;45(3):
pubmed: 34965303
Noise Health. 2012 Sep-Oct;14(60):237-43
pubmed: 23117539
Sleep. 2020 Sep 14;43(9):
pubmed: 32211778
Sleep. 2015 Jun 01;38(6):867-75
pubmed: 25515109
Sleep Med Rev. 2017 Dec;36:29-42
pubmed: 28385478
Sleep. 2011 Jan 01;34(1):11-23
pubmed: 21203365
Pulse (Basel). 2017 Jan;4(4):180-192
pubmed: 28229053
Int J Environ Res Public Health. 2018 Nov 17;15(11):
pubmed: 30453618
Percept Mot Skills. 1990 Feb;70(1):129-30
pubmed: 2326111
Med J Aust. 2002 Jun 17;176(12):588-92
pubmed: 12064958
Clin Neurophysiol. 2016 Feb;127(2):1428-1435
pubmed: 26480833
Sleep. 2015 Aug 01;38(8):1297-303
pubmed: 26158894
J Acoust Soc Am. 2021 Apr;149(4):2238
pubmed: 33940893
Environ Health. 2011 Sep 14;10:78
pubmed: 21914211
Am Fam Physician. 2004 Nov 1;70(9):1713-20
pubmed: 15554489
PLoS One. 2013 Oct 16;8(10):e76584
pubmed: 24146893
J Occup Environ Med. 2014 Nov;56(11):e108-30
pubmed: 25376420
Sleep Med Rev. 2021 Feb;55:101385
pubmed: 33007706
Sleep. 2011 May 01;34(5):601-8
pubmed: 21532953
Sleep. 2021 Sep 13;44(9):
pubmed: 33768252
Philos Trans R Soc Lond B Biol Sci. 1982 Jun 25;298(1089):199-209
pubmed: 6125971
J Anxiety Disord. 2001 Jul-Aug;15(4):287-97
pubmed: 11474815
J Acoust Soc Am. 2015 Mar;137(3):1356-65
pubmed: 25786948
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
J Sleep Res. 2021 Aug;30(4):e13228
pubmed: 33179850
Noise Health. 2014 Mar-Apr;16(69):116-22
pubmed: 24804716

Auteurs

Nathaniel S Marshall (NS)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Garry Cho (G)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.

Brett G Toelle (BG)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Renzo Tonin (R)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.
Renzo Tonin Associates, Sydney, Australia (Retired).

Delwyn J Bartlett (DJ)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Angela L D'Rozario (AL)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.
School of Psychology, Faculty of Science, University of Sydney, Sydney, New South Wales, Australia.

Carla A Evans (CA)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.

Christine T Cowie (CT)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.
Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia.
South West Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Oliver Janev (O)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.

Christopher R Whitfeld (CR)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.

Nick Glozier (N)

Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia.

Bruce E Walker (BE)

Channel Islands Acoustics, Santa Barbara, California, USA (Retired).

Roo Killick (R)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.

Miriam S Welgampola (MS)

Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia.

Craig L Phillips (CL)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.
School of Medicine, Macquarie University, Sydney, New South Wales, Australia.

Guy B Marks (GB)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.
Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia.
South West Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Ronald R Grunstein (RR)

Woolcock Institute for Medical Research, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH